IIT Hyderabad researchers develop sensor device to detect heart diseases

Image
ANI
Last Updated : Aug 19 2019 | 5:55 PM IST

Researchers at Indian Institute of Technology (IIT) Hyderabad are collaborating with research institutions across the world to develop a device to detect heart diseases with high speed, sensitivity and reliability.

Their ground-breaking work has recently been published in the reputed peer-reviewed Journal of Materials Chemistry B.

A press note issued by IIT Hyderabad on Monday said, "The research team is headed by Professor Renu John Head, Department of Biomedical Engineering, IIT Hyderabad."

"Their work not only offers promise in the diagnosis or prediction of heart disorders within minutes but can also be extended to the detection of other diseases," it added.

The note further said, "The clinical complications of Cardiovascular Diseases (CVD) are presently major causes of morbidity and mortality worldwide. Primary and specialist health providers use a variety of tools for both clinical assessment of existing heart diseases and to identify vulnerable patients at risk for CVD. Biosensors are one such tool."

"Professor John's study on microfluidics would help in building biomarker-based biosensors that could be used for instantaneous detection of heart attack and other cardiac diseases," the note said.

Elaborating on this collaborative multi-institutional Research, John said, "Biomarkers are biological molecules that represent health and disease states. They are specific chemicals that are released in the body in response to certain physiological conditions."

"Cardiac troponins or cTns, for example, are biomarkers of heart diseases and are conventionally detected in the bloodstream using antibodies that bind specifically to them. Biosensors are devices that combine the sensing element (e.g. antibody) with a transducer that converts the interaction of antibody into an electrical or optical signal that can be measured. Conventional biosensing includes such techniques as ELISA, chemiluminescent immunoassay and radioimmunoassay," he said.

Professor BD Malhotrawho collaborated in this research from Delhi Technological University said, "The major issue with the conventional assays for the detection of cTns relates to poor sensitivity and limit of detection. Improvements in detecting biosensors such as cTns in the blood require improvements in the design of the biosensor.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 19 2019 | 5:41 PM IST

Next Story